Despite inconclusive efficacy data and concerning safety data, the use of performanceenhancing drugs (PEDs) in the adolescent population is on the rise. Anabolic-androgenic steroids, growth hormones, stimulants, and erythropoiesis-stimulating agents are among the most widely known and studied prescription PEDs in the adolescent population. The purpose of this article is to describe the proposed mechanism of action, efficacy and adverse effects of these agents as well as discuss prevention measures and treatment considerations for those patients at risk for, considering, or currently using PEDs.
All Science Journal Classification (ASJC) codes
- Medicine (miscellaneous)
- Health Policy
- Public Health, Environmental and Occupational Health